New data presented at ASH 2018 from an ongoing phase I clinical trial of CAR T cell therapy in relapsed/refractory myelomaConferences, MyelomaDecember 4, 2018
Trust in non-conventional therapies by cancer patients not matched with proper awareness about their risksConferencesOctober 11, 2018
MPE present at the XXXVI World Congress of the International Society of HematologyConferences, MPEApril 19, 2016
